Skip to main content
$27.43 -$0.09 (-0.3%)

03:09 PM EDT on 09/26/22

Inmode Ltd (NASDAQ:INMD)

CAPS Rating: 5 out of 5

Current Price $27.43 Mkt Cap $2.3B
Open $26.96 P/E Ratio 13.44
Prev. Close $27.52 Div. (Yield) $0.00 (0.0%)
Daily Range $26.10 - $28.54 Volume 1,315,112
52-Wk Range $20.60 - $99.27 Avg. Daily Vol. 1,460,292

Caps

How do you think NASDAQ:INMD will perform against the market?

Add Stock to CAPS Watchlist

All Players

234 Outperform
0 Underperform
 

All-Star Players

30 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:INMD Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

maxxoni (49.07)
Submitted April 25, 2022

Absolute no-brainer. A leading global provider of innovative minimally invasive & non-invasive surgery>> low-cost compared to traditional surgery -> more affordable for the end-user>> a ton of optionality (ophthalmology, snoring, urology)>> extreme… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:INMD Summary

Fools bullish on NASDAQ:INMD are also bullish on:

Fools bearish on NASDAQ:INMD are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about INMD.

Recs

0
Member Avatar Kentuckyfarmer (< 20) Submitted: 7/21/2022 9:17:53 AM : Outperform Start Price: $29.80 NASDAQ:INMD Score: -0.51

High Growth company at a reasonable valuation.

Recs

0
Member Avatar Willfire (30.12) Submitted: 5/23/2022 4:19:03 PM : Outperform Start Price: $22.97 NASDAQ:INMD Score: +26.42

Look at the margins, look at the proposition, look at the advantages of the technology; the universe is lazy, and hates a vacuum; Good Value, and Better Growth

Recs

1
Member Avatar maxxoni (49.07) Submitted: 4/25/2022 10:13:36 AM : Outperform Start Price: $27.41 NASDAQ:INMD Score: +13.39

Absolute no-brainer. A leading global provider of innovative minimally invasive & non-invasive surgery
>> low-cost compared to traditional surgery -> more affordable for the end-user
>> a ton of optionality (ophthalmology, snoring, urology)
>> extreme profitability (ROA 40%, ROE 46%)
>> robust growth (5Y CAGR: Revenue 73%, EPS 225%)
>> no debt
>> ridiculously cheap (P/E: Current 14.3x, Forward 11.5x, P/FCF 14,5x)

Leaderboard

Find the members with the highest scoring picks in INMD.

Score Leader

allforone

allforone (83.01) Score: +620.37

The Score Leader is the player with the highest score across all their picks in INMD.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
abdeldiab < 20 3/19/2020 Outperform 3Y $9.06 +202.16% +50.29% +151.87 0 Comment
cljeffrie < 20 9/4/2019 Outperform 5Y $10.13 +170.32% +24.18% +146.14 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. gunda7907 < 20 8/30/2019 Outperform 5Y $10.13 +170.19% +24.52% +145.67 0 Comment
stocksracer 48.64 3/20/2020 Outperform 5Y $9.33 +193.51% +50.08% +143.43 0 Comment
aordinaryguy 68.23 3/12/2020 3/7/2022 Outperform 3Y $9.75 +180.86% +45.03% +135.83 0 Comment
stevec78 79.53 4/6/2020 Outperform 5Y $10.27 +166.50% +41.19% +125.32 0 Comment
bonjourmesamis < 20 4/6/2020 Outperform 5Y $10.27 +166.50% +41.19% +125.32 0 Comment
TMFHorst 84.94 4/3/2020 Outperform 5Y $10.13 +170.32% +45.17% +125.15 0 Comment
juanpo 81.29 5/14/2020 Outperform 5Y $11.36 +140.93% +30.51% +110.42 0 Comment
TMFTripleOption < 20 4/22/2020 Outperform 3Y $11.65 +134.94% +30.79% +104.15 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for INMD.